respiratory syncytial virus

News

Pfizer bulks up in RSV with $525m takeover of ReViral

Pfizer is looking to follow its vaccine/oral antiviral combination that has proved so profitable in COVID-19 with a similar approach in

News

Trailing its RSV vaccine rivals, Bavarian Nordic cuts China ...

Bavarian Nordic has licensed rights to its respiratory syncytial virus (RSV) vaccine in China and certain other Asian markets to Shanghai's Nuance Pharma in a $225 million deal.

News

After GSK stumble, Pfizer moves forward with RSV vaccine

Pfizer has been awarded breakthrough status from the FDA for its respiratory syncytial virus (RSV) vaccine in pregnant women, putting the company in pole position to bring a shot to market

News

GSK's halts RSV vaccine trials in pregnant women after pause

It looks like GlaxoSmithKline's concerns about its respiratory syncytial virus (RSV) vaccine in pregnant women aren't going to be resolved quickly.

News

Safety probe prompts GSK to halt RSV jab study in pregnant w...

GlaxoSmithKline has a lot riding on its respiratory syncytial virus (RSV) vaccine, which it thinks could be a

News

Pfizer raises pressure on GSK, J&J with late-stage RSV vacci...

Pfizer has vaulted ahead with its respiratory syncytial virus (RSV) vaccine, closing the gap with GlaxoSmithKline and Johnson & Johnson as the companies strive to bring the first licens

Pfizer bulks up in RSV with $525m takeover of ReViral

Trailing its RSV vaccine rivals, Bavarian Nordic cuts China ...

After GSK stumble, Pfizer moves forward with RSV vaccine

GSK's halts RSV vaccine trials in pregnant women after pause

Safety probe prompts GSK to halt RSV jab study in pregnant w...

Pfizer raises pressure on GSK, J&J with late-stage RSV vacci...

Lilly bags FDA okay for Wegovy pill rival orforglipron

Using AI-driven synthetic personas to take your insights fur...

respiratory syncytial virus

Editor's Picks